Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide

BACKGROUND: The efficacy of and overall survival associated with metastatic castration-resistant prostate cancer (CRPC) treatments rely on patients' consistent adherence to the recommended dosage regimens. OBJECTIVES: To evaluate treatment patterns and patient adherence to abiraterone acetate o...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Am Health Drug Benefits
Main Authors: Behl, Ajay S., Ellis, Lorie A., Pilon, Dominic, Xiao, Yongling, Lefebvre, Patrick
Format: Artigo
Sprog:Inglês
Udgivet: Engage Healthcare Communications, LLC 2017
Fag:
Clinical
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5620511/
https://ncbi.nlm.nih.gov/pubmed/28975013
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker